Cargando…
Expression of SATB1 and HER2 in breast cancer and the correlations with clinicopathologic characteristics
BACKGROUND: Special AT-rich sequence binding protein 1 (SATB1) is found acting as a “genome organizer” that functions as a landing platform to regulate tissue-specific gene ex-pression. In breast cancer cell lines it has been proven that SATB1 could upregulate the expression of the HER2. In this pap...
Autores principales: | Liu, Xiangdong, Zheng, Yan, Qiao, Chuanwu, Qv, Fei, Wang, Jingnan, Ding, Butong, Sun, Yuping, Wang, Yunshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424537/ https://www.ncbi.nlm.nih.gov/pubmed/25956130 http://dx.doi.org/10.1186/s13000-015-0282-4 |
Ejemplares similares
-
The mRNA expression of SATB1 and SATB2 in human breast cancer
por: Patani, Neill, et al.
Publicado: (2009) -
Expression of SATB1 and E-cad in tissues of patients with endometrial carcinoma and the relationship with clinicopathological features
por: Feng, Yanli, et al.
Publicado: (2018) -
HER2, NF-κB, and SATB1 Expression Patterns in Gastric Cancer and Their Correlation with Clinical and Pathological Parameters
por: Smolińska, Marta, et al.
Publicado: (2019) -
Clinicopathological Characteristics and Prognosis of HER2-Low Early-Stage Breast Cancer: A Single-Institution Experience
por: Xu, Hangcheng, et al.
Publicado: (2022) -
mRNA expression of delta-HER2 and its clinicopathological correlation in HER2-overexpressing breast cancer
por: Wada, Ryuichi, et al.
Publicado: (2016)